CompletedNot Applicable

Study of HIV, HCV, APS and Phylogenetics for PWID

Kenya4,301 participantsStarted 2018-02-26

Plain-language summary

This study will determine whether assisted partner notification services (APS) can identify and link to care, the sexual and needle-sharing partners of HIV-infected and HIV/hepatitis C (HCV) co-infected persons who inject drugs (PWID). It will also define the risk factors for onward HIV and HCV transmission among PWID using viral phylogenetics.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * \> or = 18 years of age * Active intravenous drug use (IDU) as defined by injecting at least twice in the past month * Willing and able to provide informed consent * HIV infected (either new diagnosis or known diagnosis) * Willing and able to provide locator information for sexual and/or injecting partners Exclusion Criteria: • Classified as at high risk for IPV\* \*Participants will be classified as at moderate risk for IPV if they report 1) history of IPV during their lifetime either from a current or past partner; and/or 2) fear of IPV if they participate in the study.

What they're measuring

Sexual partners tested

Timeframe: 4 years

Injecting partners tested

Timeframe: 4 years

Partners diagnosed with HIV and HCV

Timeframe: 4 years

HIV-infected partners linked to HIV care

Timeframe: 4 years

HCV-infected partners linked to HCV care

Timeframe: 4 years

Index participants linked to HIV and HCV care

Timeframe: 4 years

Trial details

NCT IDNCT03447210

SponsorUniversity of Washington

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-28

View on ClinicalTrials.gov More HIV/AIDS trials